Lv3
339 积分 2022-02-15 加入
Omadacycline
7天前
已完结
Efgartigimod alfa/Immune globulin/Immunosuppressants
1个月前
已完结
Returning to PARP inhibition: Rechallenge with Bevacizumab in Ovarian Cancer
3个月前
已完结
Two Cases of Severe Chlamydia psittaci Pneumonia with Respiratory Failure and Literature Review
3个月前
已关闭
Sustained Disease Control with Niraparib in a Pediatric Patient withRecurrent Atypical Teratoid/Rhabdoid Tumor: A Case Report
4个月前
已完结
Omadacycline
4个月前
已完结
CLO26-104: TBCRC 050: A Phase 1b/2 Trial of Niraparib and Trastuzumab in HER2+ Metastatic Breast Cancer (MBC): Safety and Efficacy
4个月前
已关闭
T315I-mutated chronic myeloid leukemia with blast crisis relapse 10 years after allo-HSCT: A case report of second transplantation combined with olverembatinib maintenance therapy
5个月前
已关闭
Olverembatinib-Based Therapy in Patients With Transformed Chronic Myeloid Leukemia in Lymphoid Blast Phase or Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Multicenter Retrospective Study
5个月前
已完结
Efgartigimod alfa
5个月前
已完结
皖公网安备34019202002308
